News on the Division of Blood Diseases and Resources

Division of Blood Diseases and Resources
3D rendered image shows a close-up image of a sickle-shaped red blood cell surrounded by mixture of normal blood cells and sickled cells.
|
News Release
‘Low-intensity’ blood stem cell transplants for sickle cell appear safe for lung health
NIH study finds lung function remained stable or improved in adults after transplant So-called low-intensity blood stem cell transplants, which use milder conditioning agents than standard stem cell transplants, do not appear to damage the lungs and may help improve lung function in some patients with sickle cell disease (SCD), according to a three...
exterior of Rural Heart and Lung Study's mobile exam unit
|
Research Feature
A High-tech Research Clinic on Wheels
NHLBI study assesses health of residents in rural South for heart, lung disease Adults in the rural South region, which includes Appalachia and the Mississippi Delta, have some of the highest rates of heart disease, obesity, high blood pressure, and chronic obstructive pulmonary disease (COPD) in the country. Heart failure rates, for example, are...
Dr. Gary Gibbons and Dr. Julie Panepinto
|
Research Features
FDA approval of gene therapies for sickle cell disease: Q&A with NHLBI Director Dr. Gary Gibbons and NHLBI’s Division of Blood Diseases and Resources Director Dr. Julie Panepinto
The U.S. Food and Drug Administration approved two new gene therapies to treat sickle cell disease — one a gene-editing and the other a gene-addition approach. Nearly 100,000 people in the United States — and millions worldwide — have been diagnosed with this painful, life-threatening genetic blood disease. To help explain the historic importance...
A 3D illustration of a blood clot is shown.
|
Research Feature
Blood thinners and COVID: The findings guiding patient care
ACTIV-4 research has provided clinicians with guidance for treating and reducing risks for severe COVID outcomes related to inflammation and blood clotting When SARS-CoV-2, the virus that causes COVID-19, first emerged in late 2019, researchers quickly assembled to understand its effects and figure out how to stop its spread. Soon, late-night phone...